Quantum Genesis AI Corp. Reports $4.4M Net Loss in H1 FY2026 Despite Slashed Spending
Quantum Genesis AI Corp., a Nevada-based artificial intelligence company, posted a net loss of $4.38 million for the six months ending January 31, 2026, up sharply from an $89,329 loss in the same period a year earlier. The company reported no revenue.
Quantum Genesis AI Corp., a Nevada-based artificial intelligence development company, posted a net loss of $4.38 million for the six months ending January 31, 2026, a dramatic widening from an $89,329 loss in the same period a year earlier. The company reported no revenue in either period. Read more earnings reports.
The net loss for the most recent quarter ending January 31, 2026 reached $4.33 million, compared to a $29,806 loss in the same quarter last year. The company has operated without generating revenue throughout both periods.
Operating expenses dropped sharply to $40,578 for the six-month period, down from $85,468 a year earlier. The most recent quarter showed operating expenses of just $1,382, down 94% from $24,534 in the prior-year quarter. Despite the reduced burn rate, interest expense climbed to $13,075 for the six-month period from $3,861 a year earlier.
The company's cash position deteriorated to $59 as of January 31, 2026, down from $584 at the end of fiscal 2025 on July 31, 2025. Cash from operations consumed $43,810 during the six-month period, while financing activities brought in $43,285.
Total liabilities stood at $418,401 as of January 31, 2026, down from $441,301 six months earlier. Stockholders' deficit deepened to negative $418,342 from negative $440,717 at the prior fiscal year-end. The company's retained deficit widened to negative $10.02 million from negative $5.64 million.
Common shares outstanding increased to 40.97 million from 38.96 million shares at the end of fiscal 2025. Additional paid-in capital rose to $9.60 million from $5.20 million, reflecting equity-based financing activity during the period.
The company recorded a diluted loss per share of $0.11 for the six-month period, compared to a loss of less than $0.01 per share in the prior-year period, based on 38.96 million weighted average shares outstanding.
Financial Summary
| Metric | Six Months Ending Jan 31, 2026 | Six Months Ending Jan 31, 2025 |
|---|---|---|
| Total Revenue | $0 | $0 |
| Operating Expenses | $40,578 | $85,468 |
| Operating Loss | ($40,578) | ($85,468) |
| Interest Expense | $13,075 | $3,861 |
| Net Loss | ($4,379,525) | ($89,329) |
| Diluted EPS | ($0.11) | ($0.00) |
| Cash & Cash Equivalents | $59 | $1,754 |
| Total Assets | $59 | N/A |
| Total Liabilities | $418,401 | N/A |
| Stockholders' Deficit | ($418,342) | ($373,128) |